-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vas-01 in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vas-01 in Hepatocellular Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Vas-01 in Hepatocellular Carcinoma Drug Details:Vas-01 (Recombinant fusion protein) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AWT-008
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AWT-008 Drug Details AWT-008 (JS-014) is under development for the treatment of solid tumors...